An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints
From MaRDI portal
Publication:3299101
DOI10.1002/BIMJ.201900022zbMath1436.62561OpenAlexW2968902065WikidataQ92553470 ScholiaQ92553470MaRDI QIDQ3299101
Publication date: 17 July 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201900022
phase II trialspredictive probabilityBayesian adaptive designcoprimary endpointsnested endpointsordinal endpoint
This page was built for publication: An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints